A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy
Summary
- Eligibility
- for people ages 2-17 (full criteria)
- Location
- at UC Davis UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bristol-Myers Squibb
- Links
- BMS Clinical Trial Information BMS Clinical Trial Patient Recruiting
- ID
- NCT05470985
- Phase
- Phase 2/3 research study
- Study Type
- Interventional
- Participants
- Expecting 120 study participants
- Last Updated